[1]
|
Wyles, C.C., Houdek, M.T., Crespo-Diaz, R.J., et al. (2015) Adipose-Derived Mesenchymal Stem Cells Are Phenotypically Superior for Regeneration in the Setting of Osteonecrosis of the Femoral Head. Clinical Orthopaedics and Related Research, 473, 3080-3090. https://doi.org/10.1007/s11999-015-4385-8
|
[2]
|
Mont, M.A., Cherian, J.J., Sierra, R.J., et al. (2015) Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today? A Ten-Year Update. The Journal of Bone and Joint Surgery, 97, 1604-1627.
https://doi.org/10.2106/JBJS.O.00071
|
[3]
|
Nam, D., Nunley, R.M., Sauber, T.J., et al. (2015) Incidence and Location of Pain in Young, Active Patients Following Hip Arthroplasty. The Journal of Arthroplasty, 30, 1971-1975. https://doi.org/10.1016/j.arth.2015.05.030
|
[4]
|
Gundtoft, P.H., Pedersen, A.B., Varnum, C., et al. (2017) Increased Mortality after Prosthetic Joint Infection in Primary THA. Clinical Orthopaedics and Related Research, 475, 2623-2631. https://doi.org/10.1007/s11999-017-5289-6
|
[5]
|
Cherian, J.J., Jauregui, J.J., Banerjee, S., et al. (2015) What Host Factors Affect Aseptic Loosening after THA and TKA? Clinical Orthopaedics and Related Research, 473, 2700-2709. https://doi.org/10.1007/s11999-015-4220-2
|
[6]
|
Arshi, A., Leong, N.L., Wang, C., et al. (2019) Outpatient Total Hip Arthroplasty in the United States: A Population-Based Comparative Analysis of Complication Rates. Journal of the American Academy of Orthopaedic Surgeons, 27, 61-67. https://doi.org/10.5435/JAAOS-D-17-00210
|
[7]
|
Wang, X., Wang, Y., Gou, W., et al. (2013) Role of Mesenchymal Stem Cells in Bone Regeneration and Fracture Repair: A Review. International Orthopaedics, 37, 2491-2498. https://doi.org/10.1007/s00264-013-2059-2
|
[8]
|
Wang, A., Ren, M., Wang, J. (2018) The Pathogenesis of Steroid-Induced Osteonecrosis of the Femoral Head: A Systematic Review of the Literature. Gene, 671, 103-109. https://doi.org/10.1016/j.gene.2018.05.091
|
[9]
|
Fu, X., Liu, G., Halim, A., et al. (2019) Mesenchymal Stem Cell Migration and Tissue Repair. Cells, 8, 784.
https://doi.org/10.3390/cells8080784
|
[10]
|
Haumer, A., Bourgine, P.E., Occhetta, P., et al. (2018) Delivery of Cellular Factors to Regulate Bone Healing. Advanced Drug Delivery Reviews, 129, 285-294. https://doi.org/10.1016/j.addr.2018.01.010
|
[11]
|
Bai, Y., Li, P., Yin, G., et al. (2013) BMP-2, VEGF and bFGF Synergistically Promote the Osteogenic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells. Biotechnology Letters, 35, 301-308.
https://doi.org/10.1007/s10529-012-1084-3
|
[12]
|
Xiao, Y., Peperzak, V., Van Rijn, L., et al. (2010) Dexamethasone Treatment during the Expansion Phase Maintains Stemness of Bone Marrow Mesenchymal Stem Cells. Journal of Tissue Engineering and Regenerative Medicine, 4, 374-386. https://doi.org/10.1002/term.250
|
[13]
|
Han, N., Li, Z., Cai, Z., et al. (2016) P-glycoprotein Overexpression in Bone Marrow-Derived Multipotent Stromal Cells Decreases the Risk of Steroid-Induced Osteonecrosis in the Femoral Head. Journal of Cellular and Molecular Medicine, 20, 2173-2182. https://doi.org/10.1111/jcmm.12917
|
[14]
|
Dai, Z., Jin, Y., Zheng, J., et al. (2019) MiR-217 Promotes Cell Proliferation and Osteogenic Differentiation of BMSCs by Targeting DKK1 in Steroid-Associated Osteonecrosis. Biomedicine & Pharmacotherapy, 109, 1112-1119.
https://doi.org/10.1016/j.biopha.2018.10.166
|
[15]
|
Israelite, C., Nelson, C.L., Ziarani, C.F., et al. (2005) Bilateral Core Decompression for Osteonecrosis of the Femoral Head. Clinical Orthopaedics and Related Research, 441, 285-290.
https://doi.org/10.1097/01.blo.0000192365.58958.84
|
[16]
|
Rajagopal, M., Balch Samora, J., Ellis, T.J. (2012) Efficacy of Core Decompression as Treatment for Osteonecrosis of the Hip: A Systematic Review. HIP International, 22, 489-493. https://doi.org/10.5301/HIP.2012.9748
|
[17]
|
Tabatabaee, R.M., Saberi, S., Parvizi, J., et al. (2015) Combining Concentrated Autologous Bone Marrow Stem Cells Injection with Core Decompression Improves Outcome for Patients with Early-Stage Osteonecrosis of the Femoral Head: A Comparative Study. The Journal of Arthroplasty, 30, 11-15. https://doi.org/10.1016/j.arth.2015.06.022
|
[18]
|
Rastogi, S., Sankineani, S.R., Nag, H.L., et al. (2013) Intralesional Autologous Mesenchymal Stem Cells in Management of Osteonecrosis of Femur: A Preliminary Study. Musculoskeletal Surgery, 97, 223-228.
https://doi.org/10.1007/s12306-013-0273-0
|
[19]
|
Sen, R.K., Tripathy, S.K., Aggarwal, S., et al. (2012) Early Results of Core Decompression and Autologous Bone Marrow Mononuclear Cells Instillation in Femoral Head Osteonecrosis: A Randomized Control Study. The Journal of Arthroplasty, 27, 679-686. https://doi.org/10.1016/j.arth.2011.08.008
|
[20]
|
Kinnaird, T., Stabile, E., Burnett, M.S., et al. (2004) Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote in Vitro and in Vivo Arteriogenesis through Paracrine Mechanisms. Circulation Research, 94, 678-685. https://doi.org/10.1161/01.RES.0000118601.37875.AC
|
[21]
|
Jin, H., Xia, B., Yu, N., et al. (2012) The Effects of Autologous Bone Marrow Mesenchymal Stem Cell Arterial Perfusion on Vascular Repair and Angiogenesis in Osteonecrosis of the Femoral Head in Dogs. International Orthopaedics, 36, 2589-2596. https://doi.org/10.1007/s00264-012-1674-7
|
[22]
|
Mao, Q., Jin, H., Liao, F., et al. (2013) The Efficacy of Targeted Intraarterial Delivery of Concentrated Autologous Bone Marrow Containing Mononuclear Cells in the Treatment of Osteonecrosis of the Femoral Head: A Five Year Follow-Up Study. Bone, 57, 509-516. https://doi.org/10.1016/j.bone.2013.08.022
|
[23]
|
Ma, X.W., Cui, D., Zhao, D., et al. (2015) Vascular Endothelial Growth Factor/Bone Morphogenetic Protein-2 Bone Marrow Combined Modification of the Mesenchymal Stem Cells to Repair the Avascular Necrosis of the Femoral Head. International Journal of Clinical and Experimental Medicine, 8, 15528-15534.
|
[24]
|
Peng, W.X., Wang, L. (2017) Adenovirus-Mediated Expression of BMP-2 and BFGF in Bone Marrow Mesenchymal Stem Cells Combined with Demineralized Bone Matrix for Repair of Femoral Head Osteonecrosis in Beagle Dogs. Cellular Physiology and Biochemistry, 43, 1648-1662. https://doi.org/10.1159/000484026
|
[25]
|
Kang, J.S., Moon, K.H., Kim, B.S., et al. (2013) Clinical Results of Auto-Iliac Cancellous Bone Grafts Combined with Implantation of Autologous Bone Marrow Cells for Osteonecrosis of the Femoral Head: A Minimum 5-Year Follow-Up. Yonsei Medical Journal, 54, 510-515. https://doi.org/10.3349/ymj.2013.54.2.510
|
[26]
|
Kang, P., Xie, X., Tan, Z., et al. (2015) Repairing Defect and Preventing Collapse of Femoral Head in a Steroid-Induced Osteonecrotic of Femoral Head Animal Model Using Strontium-Doped Calcium Polyphosphate Combined BM-MNCs. Journal of Materials Science: Materials in Medicine, 26, 80. https://doi.org/10.1007/s10856-015-5402-x
|
[27]
|
Hauzeur, J.P., De Maertelaer, V., Baudoux, E., et al. (2018) Inefficacy of Autologous Bone Marrow Concentrate in Stage Three Osteonecrosis: A Randomized Controlled Double-Blind Trial. International Orthopaedics, 42, 1429-1435.
https://doi.org/10.1007/s00264-017-3650-8
|
[28]
|
Piuzzi, N.S., Chahla, J., Schrock, J.B., et al. (2017) Evidence for the Use of Cell-Based Therapy for the Treatment of Osteonecrosis of the Femoral Head: A Systematic Review of the Literature. The Journal of Arthroplasty, 32, 1698-1708.
https://doi.org/10.1016/j.arth.2016.12.049
|
[29]
|
Wang, Y., Han, Z.B., Song, Y.P., et al. (2012) Safety of Mesenchymal Stem Cells for Clinical Application. Stem Cells International, 2012, Article ID: 652034. https://doi.org/10.1155/2012/652034
|
[30]
|
Santelli, J., Lechevallier, S., Baaziz, H., et al. (2018) Multimodal Gadolinium Oxysulfide Nanoparticles: A Versatile Contrast Agent for Mesenchymal Stem Cell Labeling. Nanoscale, 10, 16775-16786.
https://doi.org/10.1039/C8NR03263G
|